We recently published 10 Stocks Leaving Wall Street in the Dust; 4 Hit Fresh Records. Moderna Inc. (NASDAQ:MRNA) was one of ...
Moderna shares surge 30% in 2026 on raised revenue forecast and cost cuts. Technical breakout suggests continued momentum ...
Zacks Investment Research on MSN
Moderna (MRNA) increases despite market slip: Here's what you need to know
Moderna (MRNA) closed at $40.60 in the latest trading session, marking a +2.52% move from the prior day. The stock's change ...
Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...
The safety of mRNA vaccines, hailed as a saviour in the covid-19 pandemic, has been called into question by the US ...
In early January 2026, Moderna filed for marketing authorization of its investigational seasonal influenza vaccine mRNA-1010 ...
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for ...
Live Science on MSN
An experimental mRNA treatment counters immune cell aging in mice
A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results